Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Bullboard Posts
Post by SizzlinSteakson Jun 07, 2018 8:47am
146 Views
Post# 28138070

My guess.....

My guess.........is that we are close to a JV announcement based on the fact that the recent PP was only offered to insiders and friends ....and was done for a mere $1 million dollars. Certainly this is not enough cash to take them into phase 2.  This indicates they only wanted to raise enough to tie them over until they firm up a deal with a major pharmaceutical to proceed to phase 2.

A partnership with a major should provide an influx of sufficient $$$ to advance all their indications. This should take us to the next level and hopefully get us off this rotten venture exchange and move us to a major exchange where this belongs. Then we can finally get a respectful valuation. I beileve we are close ( within 3 months) and our patience should finally pay off. 

Cheers!
Bullboard Posts